Skip to content

Company · founded 2006

RadioMedix (United States)

Houston, United States · radiomedix.com

Manage this page

Citations, last 5 years: 242
Works, last 5 years: 15
h-index: 38
Scientists listed: 1
Grants since 2016: 4

Grants received

2021–2023 · research · R44

Targeted alpha-emitter therapy of patients with PRRT refractory neuroendocrine tumors

Izabela Tworowska · RadioMedix (United States) · funded by National Institutes of Health

$548.2kNeuroendocrine Tumor Research Advances

2021–2024 · research · R44

Targeted alpha-emitter therapy of patients with PRRT refractory neuroendocrine tumors

Izabela Tworowska · RadioMedix (United States) · funded by National Institutes of Health

$1.5MNeuroendocrine Tumor Research Advances

2018–2020 · contract · N01

IGF::OT::IGFNCI SBIR Phase II Topic 346: Molecularly Targeted Radiation Therapy for Cancer TreatmentTitle: Targeted Radionuclide Therapy of Neuroendocrine Tumors using 212Pb-octreotate Analogs

Izabela Tworowska · RadioMedix (United States) · funded by National Institutes of Health

$2M

2016–2017 · contract · N43

IGF::OT::IGF TARGETED RADIONUCLIDE THERAPY OF NEUROENDOCRINE TUMORS USING PB212-OCTREOTATE ANALOGS

Izabela Tworowska · RadioMedix (United States) · funded by National Institutes of Health

$298.1k